Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban Compared to Warfarin for Treatment of Cerebral Venous Thrombosis: a Randomized Controlled Trial

NCT04569279 is registered in ClinicalTrials.gov with Damascus University as lead sponsor.

NCT NCT04569279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban Compared to Warfarin for Treatment of Cerebral Venous Thrombosis: a Randomized Controlled Trial
Lead sponsor
Damascus University
Phase
Phase 3
Overall status
Completed
Start date
September 1, 2017
Completion date
March 1, 2020
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vein thrombosis